Delivering a CRISPR-Cas-derived adenine base editor as a short-lived protein-guide RNA complex enabled efficient PCSK9 ...
The US FDA has accepted Intellia Therapeutics’ application for lonvoguran ziclumeran (lonvo-z, formerly NTLA-2002) and ...
Global adoption growing with more than 400 institutions across 33 countries ordering DNA constructs up to 49.1 kb, with ...
Delivering CRISPR-Cas9 as mRNA in lipid nanoparticles preserved the fitness and erythroid potential of edited human ...
A gene-edited pig kidney kept a patient with end-stage kidney disease dialysis-free for 271 days, then failed and was removed without leaving the recipient sensitised against human donors. Eighty-two ...
Precision BioSciences reported progress with its CRISPR-Cas–based ARCUS gene editing therapy PBGENE-DMD, designed to excise dystrophin exons 45–55 and restore near full-length dystrophin expression.
Delivering a CRISPR-Cas-derived adenine base editor as a short-lived protein-guide RNA complex... CRISPR Trials Global Overview Q2 2026 from CMN... Sep. 10, 2026 CMN Intelligence has released the CMN ...
Researchers have used a novel CRISPR-Cas library to identify essential microRNAs in prostate cancer cells, revealing miR-483-3p as a key regulator of cell survival. The study found that disrupting ...
In vivo genome editing is entering an important new phase. Advances in editing technologies, delivery platforms and translational science are bringing the prospect of one-time, directly administered ...
(Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell and in vivo CAR T therapies for autoimmune diseases, hematologic malignancies and ...
Some of the best links we picked up around the internet On Wednesday, we reported the announcement from YolTech Therapeutics that the Chinese National Medical Products Administration has approved its ...
Dr. Christiano Alves (left), is a junior faculty member (Instructor) in the laboratory of Dr. Ben Kleinstiver (right) in the Center for Genomic Medicine at Massachusetts General Hospital. Their recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results